A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer
Clinical trial NCT07358585 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07358585
- Sponsor
- Shanghai Henlius Biotech
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-31
- Primary completion
- 2027-07-28
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.